Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | VDR | P11473 | 3/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 12/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 8/20 | 0.37 |
| ▸ | RXRA | P19793 | 1/20 | 0.35 |
| ▸ | RARB | P10826 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5703376 | 1.00 | HDAC3 (0.41) | HDAC3HDAC6VDRFFAR4FFAR1 | |
| SCHEMBL5703454 | 0.88 | HDAC6 (0.39) | HDAC3HDAC6VDRFFAR4FFAR1 | |
| SCHEMBL5703451 | 0.88 | HDAC6 (0.39) | HDAC3HDAC6VDRFFAR4FFAR1 | |
| SCHEMBL5703439 | 0.85 | FFAR4 (0.49) | HDAC3HDAC6VDRFFAR4FFAR1 | |
| SCHEMBL6225868 | 0.84 | VDR (0.47) | VDR | |
| SCHEMBL6227729 | 0.83 | HDAC6 (0.43) | HDAC3HDAC6VDR | |
| SCHEMBL6228546 | 0.83 | HDAC6 (0.43) | HDAC3HDAC6VDR | |
| SCHEMBL5703483 | 0.80 | BCHE (0.35) | HDAC3HDAC6FFAR4FFAR1 | |
| SCHEMBL6259401 | 0.80 | HDAC3 (0.41) | HDAC3HDAC6VDRFFAR4FFAR1 | |
| SCHEMBL6259404 | 0.80 | HDAC3 (0.41) | HDAC3HDAC6VDRFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1687258-A2 | VITAMIN D RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 2006-08-09 | — | — | EP | disclosed |
| WO-2005051893-A2 | VITAMIN D RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 2005-06-09 | — | — | WO | disclosed |